Developed on a mucosal drug delivery platform, the semaglutide nasal spray offers several potential advantages: Avoids first-pass metabolism, potentially improving bioavailability Non-invasive administration, significantly enhancing patient adherence Convenient and self-administered, supporting long-term disease management As competition in the GLP-1 space intensifies across injectable and oral formulations, innovation in drug delivery is emerging as a new differentiation strategy
International Journal of Clinical Practice
Over time, however, their effects often diminish with regular use
In situations where abrupt discontinuation of topiramate is medically required, appropriate monitoring is recommended
Rights and permissions About this article Cite this article Askarpour, M., Hadi, A., Dehghani Kari Bozorg, A
Liver Fibrosis Percentage based on PSR Staining